Ginkgo Bioworks Announces Date of Second Quarter 2024 Results Presentation
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), a leading platform for cell programming and biosecurity, has announced its plans to host a presentation and Q&A session to review its second quarter 2024 business performance. The event is scheduled for Thursday, August 8, 2024, at 5:30 p.m. ET, following the market close. Investors and interested parties can access the presentation details and webcast link on Ginkgo's investor relations website. A replay of the session will be made available afterwards.
To facilitate engagement, Ginkgo is encouraging participants to submit questions in advance. Questions can be posted on X (formerly Twitter) using the hashtag #GinkgoResults or sent via email to investors@ginkgobioworks.com.
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), una piattaforma leader per la programmazione cellulare e la biosecurity, ha annunciato i suoi piani per ospitare una presentazione e una sessione di domande e risposte per rivedere le performance aziendali del secondo trimestre del 2024. L'evento è programmato per giovedì 8 agosto 2024, alle 17:30 ET, dopo la chiusura del mercato. Investitori e parti interessate possono accedere ai dettagli della presentazione e al link per la diretta streaming sul sito relazioni con gli investitori di Ginkgo. Una registrazione della sessione sarà disponibile successivamente.
Per facilitare il coinvolgimento, Ginkgo sta incoraggiando i partecipanti a inviare domande in anticipo. Le domande possono essere pubblicate su X (precedentemente Twitter) utilizzando l'hashtag #GinkgoResults o inviate via email a investors@ginkgobioworks.com.
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), una plataforma líder para la programación celular y la bioseguridad, ha anunciado sus planes para realizar una presentación y una sesión de preguntas y respuestas para revisar su rendimiento comercial del segundo trimestre de 2024. El evento está programado para jueves 8 de agosto de 2024, a las 5:30 p.m. ET, tras el cierre del mercado. Los inversionistas y las partes interesadas pueden acceder a los detalles de la presentación y al enlace de transmisión en vivo en el sitio web de relaciones con inversores de Ginkgo. Se hará disponible posteriormente una repetición de la sesión.
Para facilitar la participación, Ginkgo está animando a los participantes a enviar preguntas con antelación. Las preguntas pueden publicarse en X (anteriormente Twitter) usando el hashtag #GinkgoResults o enviándose por correo electrónico a investors@ginkgobioworks.com.
징코 바이오웍스 홀딩스, Inc. (NYSE: DNA)는 세포 프로그래밍 및 생물 보안의 선도적인 플랫폼으로, 2024년 2분기 사업 실적에 대한 발표 및 Q&A 세션을 개최할 계획을 발표했습니다. 이 행사는 2024년 8월 8일 목요일 오후 5시 30분 ET에 시장 종료 후에 예정되어 있습니다. 투자자 및 관심 있는 분들은 징코의 투자자 관계 웹사이트에서 발표 세부 정보와 웨비나 링크에 접근할 수 있습니다. 세션의 재생본은 이후에 제공될 예정입니다.
참여를 촉진하기 위해 징코는 참가자들에게 사전에 질문을 제출할 것을 권장하고 있습니다. 질문은 X(구 Twitter)에서 #GinkgoResults 해시태그를 사용하여 게시하거나, investors@ginkgobioworks.com으로 이메일을 보내실 수 있습니다.
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), une plateforme de premier plan pour la programmation cellulaire et la biosécurité, a annoncé ses projets d’organiser une présentation suivie d’une session de questions-réponses pour examiner sa performance commerciale du deuxième trimestre 2024. L’événement est prévu pour le jeudi 8 août 2024, à 17h30 ET, après la clôture du marché. Les investisseurs et les parties intéressées peuvent accéder aux détails de la présentation et au lien de webdiffusion sur le site des relations avec les investisseurs de Ginkgo. Un enregistrement de la session sera disponible par la suite.
Pour faciliter l'engagement, Ginkgo encourage les participants à soumettre des questions à l'avance. Les questions peuvent être publiées sur X (anciennement Twitter) en utilisant le hashtag #GinkgoResults ou envoyées par email à investors@ginkgobioworks.com.
Ginkgo Bioworks Holdings, Inc. (NYSE: DNA), eine führende Plattform für Zellprogrammierung und Biosicherheit, hat ihre Pläne angekündigt, eine Präsentation und eine Fragerunde abzuhalten, um die geschäftliche Leistung des zweiten Quartals 2024 zu überprüfen. Die Veranstaltung ist für Donnerstag, den 8. August 2024, um 17:30 Uhr ET, nach Börsenschluss, angesetzt. Investoren und Interessierte können die Einzelheiten zur Präsentation und den Webcast-Link auf Ginkgos Investor-Relations-Website einsehen. Eine Wiederholung der Sitzung wird anschließend zur Verfügung gestellt.
Um die Teilnahme zu erleichtern, ermutigt Ginkgo die Teilnehmer, Fragen im Voraus einzureichen. Fragen können auf X (ehemals Twitter) mit dem Hashtag #GinkgoResults gepostet oder per E-Mail an investors@ginkgobioworks.com gesendet werden.
- None.
- None.
Presentation and Q&A session scheduled for post-market on Thursday, August 8, 2024
The presentation details and webcast link will be available on Ginkgo's investor relations website at https://investors.ginkgobioworks.com, and a replay will be made available.
To ask a question ahead of the presentation, please submit them to @Ginkgo on X (hashtag #GinkgoResults) or by sending an e-mail to investors@ginkgobioworks.com.
About Ginkgo Bioworks
Ginkgo Bioworks is the leading horizontal platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. Ginkgo Biosecurity is building and deploying the next-generation infrastructure and technologies that global leaders need to predict, detect, and respond to a wide variety of biological threats. For more information, visit ginkgobioworks.com and ginkgobiosecurity.com, read our blog, or follow us on social media channels such as X (@Ginkgo and @Ginkgo_Biosec), Instagram (@GinkgoBioworks), Threads (@GinkgoBioworks) or LinkedIn.
Ginkgo Bioworks Contacts:
INVESTOR CONTACT:
MEDIA CONTACT:
View original content to download multimedia:https://www.prnewswire.com/news-releases/ginkgo-bioworks-announces-date-of-second-quarter-2024-results-presentation-302210211.html
SOURCE Ginkgo Bioworks
FAQ
When will Ginkgo Bioworks (DNA) release its Q2 2024 earnings?
How can I access Ginkgo Bioworks' (DNA) Q2 2024 earnings presentation?
Can I submit questions for Ginkgo Bioworks' (DNA) Q2 2024 earnings call?
Will there be a replay available for Ginkgo Bioworks' (DNA) Q2 2024 earnings call?
